Gainers
-
Signet Jewelers Ltd. (NYSE: SIG) rose 17.5 percent
to $60.99 in pre-market trading as the company posted stronger-than-expected Q2 profit and reported a deal to buy R2Net for
$328 million in cash.
-
China Cord Blood Corp (NYSE: CO) shares rose 14.8
percent to $14.34 in pre-market trading. China Cord Blood reported Q1 earnings of $0.09 per share on sales of $33.074 million.
-
Guess?, Inc. (NYSE: GES) rose 12.2 percent to $14.00
in pre-market trading after the company reported stronger-than-expected earnings for its second quarter on Wednesday.
-
Michaels Companies Inc (NASDAQ: MIK) shares rose
10 percent to $21.57 in pre-market trading as the company posted upbeat quarterly earnings.
-
Omeros Corporation (NASDAQ: OMER) rose 9.7
percent to $23.30 in pre-market trading after dropping 0.19 percent on Wednesday.
-
Adamas Pharmaceuticals Inc (NASDAQ: ADMS) rose
9.5 percent to $15.75 in pre-market trading after gaining 0.63 percent on Wednesday.
-
Dollar Tree, Inc. (NASDAQ: DLTR) shares rose 8.9
percent to $80.90 in the pre-market trading session after the company posted upbeat quarterly earnings and increased its FY17
guidance.
-
Burlington Stores Inc (NYSE: BURL) shares rose 7.7
percent to $91.45 in pre-market trading after the company posted stronger-than-expected quarterly earnings.
-
Williams-Sonoma, Inc. (NYSE: WSM) rose 6.4 percent
to $46.15 in pre-market trading after the company posted better-than-expected earnings for its second quarter.
-
Beyondspring Inc (NASDAQ: BYSI) rose 5.4 percent
to $40.38 in pre-market trading after slipping 0.52 percent on Wednesday.
-
Fiat Chrysler Automobiles NV (NYSE: FCAU) rose 4.7
percent to $15.10 in pre-market trading. Fiat Chrysler shares surged 7percent Wednesday on news suggesting a potential spinoff
of its Maserati line and other parts.
-
PVH Corp (NYSE: PVH) shares rose 4.6 percent to
$125.50 in pre-market trading as the company reported upbeat results for its second quarter and issued a strong earnings
forecast.
-
Abercrombie & Fitch Co. (NYSE: ANF) gained 4.2
percent to $10.01 after the company posted a narrower-than-expected Q2 loss.
-
Enzymotec Ltd (NASDAQ: ENZY) rose 4.1 percent to
$11.45 in pre-market trading. Frutarom has acquired a 9.2 percent stake in Enzymotec from Paulson.
-
Synacor Inc (NASDAQ: SYNC) rose 4.1 percent to
$2.55 in pre-market trading after jumping 2.08 percent on Wednesday.
-
CRH PLC (ADR) (NYSE: CRH) shares rose 3.8 percent to
$35.59 in pre-market trading. Beacon Roofing Supply agreed to acquire Allied Building Products from CRH for $2.625B in cash.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares
fell 7.3 percent to $2.04 in pre-market trading after surging 83.33 percent on Wednesday.
-
China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU)
fell 6 percent to $15.15 in pre-market trading after declining 1.89 percent on Wednesday.
-
Centene Corp (NYSE: CNC) fell 5 percent to $81.41 in
pre-market trading after dropping 0.64 percent on Wednesday.
-
Hormel Foods Corp (NYSE: HRL) shares fell 4.8
percent to $32.30 in pre-market trading after the company reported weaker-than-expected profit for its third quarter and
lowered its FY17 earnings outlook.
-
J M Smucker Co (NYSE: SJM) shares fell 4.7 percent
to $113.29 in pre-market trading after the company posted downbeat quarterly results and lowered its FY18 forecast.
-
Pernix Therapeutics Holdings Inc (NASDAQ: PTX)
fell 4.3 percent to $2.90 in pre-market trading after jumping 13.48 percent on Wednesday.
-
YY Inc (ADR) (NASDAQ: YY) fell 2.6 percent to
$72.30 in pre-market trading after rising 0.13 percent on Wednesday.
-
HP Inc (NYSE: HPQ) fell 2.5 percent to $18.40 in
pre-market trading. HP reported stronger-than-expected results for its third quarter and raised its fiscal 2017 year outlook.
-
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) fell 2.2 percent to $16.15. Credit Suisse downgraded Teva from Neutral to
Underperform.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.